Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 628
5
Diseases
7
Unique genes
0.305
Avg. similarity score
Cutis laxa, autosomal dominant, 2
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cutis laxa, autosomal dominant, 2
Cutis laxa, autosomal recessive, 1a
Cutis laxa, autosomal recessive, type ia
Demyelinating hereditary motor and sensory neuropathy
Proximal spinal muscular atrophy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cutis laxa, autosomal dominant, 2 | 4 | 4 | 1 |
| Cutis laxa, autosomal recessive, 1a | 4 | 4 | 1 |
| Cutis laxa, autosomal recessive, type ia | 4 | 4 | 1 |
| Demyelinating hereditary motor and sensory neuropathy | 4 | 4 | 2 |
| Proximal spinal muscular atrophy | 4 | 4 | 6 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FBLN5 | 5 / 5 | Cutis laxa, autosomal dominant, 2, Cutis laxa, autosomal recessive, 1a, Cutis laxa, autosomal recessive, type ia, Demyelinating hereditary motor and sensory neuropathy and 1 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| snRNP Assembly | Reactome | 2 / 53 | 64.7× | 3.96e-4 | 5.58e-3 ✓ sig. |
| Synthesis of PIPs at the ER membrane | Reactome | 1 / 5 | 343× | 2.91e-3 | 2.49e-2 ✓ sig. |
| Synthesis of PIPs at the late endosome membrane | Reactome | 1 / 10 | 172× | 5.82e-3 | 4.03e-2 ✓ sig. |
| Synthesis of PIPs at the early endosome membrane | Reactome | 1 / 15 | 114× | 8.71e-3 | 5.22e-2 |
| Processing of SMDT1 | Reactome | 1 / 16 | 107× | 9.29e-3 | 5.43e-2 |
| Elastic fibre formation | Reactome | 1 / 18 | 95.3× | 1.04e-2 | 5.84e-2 |
| Molecules associated with elastic fibres | Reactome | 1 / 38 | 45.2× | 2.19e-2 | 9.03e-2 |
| Legionellosis | KEGG | 1 / 56 | 30.6× | 3.22e-2 | 1.13e-1 |
| Inositol phosphate metabolism | KEGG | 1 / 73 | 23.5× | 4.18e-2 | 1.31e-1 |
| Phosphatidylinositol signaling system | KEGG | 1 / 98 | 17.5× | 5.58e-2 | 1.54e-1 |
| NOD-like receptor signaling pathway | KEGG | 1 / 187 | 9.2× | 1.04e-1 | 2.21e-1 |
| Pathogenic Escherichia coli infection | KEGG | 1 / 200 | 8.6× | 1.11e-1 | 2.30e-1 |
| Salmonella infection | KEGG | 1 / 248 | 6.9× | 1.36e-1 | 2.60e-1 |
| Shigellosis | KEGG | 1 / 250 | 6.9× | 1.37e-1 | 2.61e-1 |
| Amyotrophic lateral sclerosis | KEGG | 1 / 368 | 4.7× | 1.96e-1 | 3.27e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| DNA-templated transcription termination | GO:0006353 | 3 / 13 | 616× | 9.19e-9 | 1.64e-6 ✓ sig. |
| nervous system development | GO:0007399 | 5 / 631 | 21.2× | 8.58e-7 | 7.55e-5 ✓ sig. |
| spliceosomal complex assembly | GO:0000245 | 2 / 28 | 191× | 4.53e-5 | 1.71e-3 ✓ sig. |
| spliceosomal snRNP assembly | GO:0000387 | 2 / 29 | 184× | 4.86e-5 | 1.81e-3 ✓ sig. |
| RNA splicing, via transesterification reactions | GO:0000375 | 2 / 30 | 178× | 5.21e-5 | 1.90e-3 ✓ sig. |
| negative regulation of receptor catabolic process | GO:2000645 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| positive regulation of termination of DNA-templated transcription | GO:0060566 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| intramembranous bone growth | GO:0098867 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| mitochondrial outer membrane permeabilization involved in programmed cell death | GO:1902686 | 1 / 2 | 1,335× | 7.49e-4 | 1.23e-2 ✓ sig. |
| positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled | GO:2000806 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| regulation of calcium import into the mitochondrion | GO:0110097 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| regulation of phosphatidylinositol dephosphorylation | GO:0060304 | 1 / 5 | 534× | 1.87e-3 | 2.05e-2 ✓ sig. |
| mitochondrial protein processing | GO:0034982 | 1 / 6 | 445× | 2.25e-3 | 2.24e-2 ✓ sig. |
| regulation of removal of superoxide radicals | GO:2000121 | 1 / 7 | 381× | 2.62e-3 | 2.44e-2 ✓ sig. |
| myelin assembly | GO:0032288 | 1 / 7 | 381× | 2.62e-3 | 2.44e-2 ✓ sig. |